Completed
Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS
NCT02525939
- Conditions
- Acute Coronary Syndrome, Cardiovascular Diseases, Heart Diseases, +2 more
- Locations
-
- Research Site Alexander City, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Mobile, Alabama, United States
- Research Site Cottonwood, Arizona, United States